Clinical Trial Update: Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating concomitant administration of an inactivated Hepatitis A vaccine with Haemophilus influenzae type b conjugate vaccine, a meningococcal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed)
• Haemophilus influenzae type b conjugate vaccine (Haemophilus influenzae type b conjugate vaccine)
• Hepatitis A vaccine (inactivated) (inactivated Hepatitis A vaccine)
• Meningococcal protein conjugate vaccine (Meningococcal protein-conjugate vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis A Virus | Phase 4 | Status: COMPLETED | Results posted: 2011-07-07